Morcin
FDA Label NDC 50488-2626

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Alexso, Inc for the product Morcin (NDC 50488-2626). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding warnings and precautions, other, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Warnings And Precautions

Only for external use

Do not use on open wounds, cuts, damaged or infected skin as well as in the eyes, mouth, genitals or any other mucus membranes.

Consult your physician: if pain is persistent or worsens or if using any other topical pain products.

Call poison control if swallowed. If contact with eyes occurs, rinse eyes thoroughly with cold water.

If a rash develops discontinue use and consult a physician.

Use in pregnancy or nursing mother: No studies have been done on animals or humans.

Other

Keep out of reach of children. Consult physician for children under 12.

* Please review the disclaimer below.